spacer
home > pmps > summer 2019 > all about the box
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

All About the Box

In December 2016, a pharmacist in Northern Ireland made a tragic error when he fatally dispensed propranolol to a patient who was prescribed prednisolone. It was revealed that the two boxes were side-by-side on the pharmacy’s shelf, with similar branding and packaging. Such simple slip-ups can result in devastation and highlight packaging’s crucial role in keeping patients safe.

Even to the trained eye of a busy pharmacist, medication names such as Daptomycin and Dactinomycin or Levoxine and Lanoxin could be easily muddled, especially if they share similar dosages and are packaged in indistinguishable white cardboard boxes.

Incorrect dispensing is just one issue that can arise from ineffective packaging. Dangerous storage conditions, medication tampering, and the production of counterfeit medicine can all occur when packaging is not as effective as it should be. What can we do to prevent these problems before they jeopardise public health?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Oliver Pittock is the Managing Director at pharma packaging specialist Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

Comparator Sourcing in Oncology Trials

Clinical Services International

This is an exciting time for oncology trials, year on year record numbers of therapeutics are launched and the indications for many drugs on the market are increasing rapidly. Immunotherapies and next generation biotherapeutics are being approved for more tumour types and a growing percentage of the late stage oncology pipeline are targeted biologics.
More info >>

 
Industry Events

Pharmapack Europe 2020

5-6 February 2020, Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement